Antares Pharma, Inc.
9 drugs in NADAC|0 Generic,9 Brand
Antares Pharma, Inc. lists 9 NDCs in the CMS NADAC file (0 generic, 9 brand), at an average NADAC of $325.27 per unit, with a week-over-week move of -0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
9
0G / 9B
Avg Price / Unit
$325.2703
$6.82 – $484.21
Avg 7d Change
-0.02%
Across 4 drugs with changes
7d Activity
of 9 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
methotrexate market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Folate Analog Metabolic Inhibitor therapeutic class
Review the broader class where Antares Pharma, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Antares Pharma, Inc. make?
Antares Pharma, Inc. lists 9 NDCs in the CMS NADAC file — 0 generic and 9 brand products.
What is the average price of Antares Pharma, Inc. drugs?
The average NADAC across Antares Pharma, Inc.'s portfolio is $325.2703 per unit, ranging from $6.8232 to $484.2097.
What types of drugs does Antares Pharma, Inc. make?
Antares Pharma, Inc. makes drugs across 3 FDA pharmacologic classes. The most common by NDC count are Folate Analog Metabolic Inhibitor (4), Androgen (4), Endoglycosidase (1).
Has Antares Pharma, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Antares Pharma, Inc. in the openFDA feed.
How has Antares Pharma, Inc.'s pricing changed recently?
Over the past 7 days, 1 Antares Pharma, Inc. product rose and 3 fell, with a portfolio-wide average change of -0.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OTREXUP 15 MG/0.4 ML AUTO-INJ methotrexate | $484.2097 per ML | — |
OTREXUP 20 MG/0.4 ML AUTO-INJ methotrexate | $480.8553 per ML | — |
OTREXUP 17.5 MG/0.4 ML AUTOINJ methotrexate | $476.9597 per ML | — |
OTREXUP 25 MG/0.4 ML AUTO-INJ methotrexate | $475.8075 per ML | — |
XYOSTED 100 MG/0.5 ML AUTO-INJ testosterone enanthate | $316.5006 per ML | -0.05% |
XYOSTED 75 MG/0.5 ML AUTO-INJ testosterone enanthate | $316.3804 per ML | -0.02% |
XYOSTED 50 MG/0.5 ML AUTO-INJ testosterone enanthate | $316.2082 per ML | +0.04% |
HYLENEX 150 UNITS/ML VIAL Hyaluronidase | $53.6877 per ML | -0.03% |
TLANDO 112.5 MG CAPSULE testosterone undecanoate | $6.8232 per EA | — |